Regent Peak Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,278	Closed	-$322K	–	172
2023 Q4	$322K	Sell	6,278 -28,697	-82%	-$1.51M	0.09%	106
2023 Q3	$2.03M	Buy	34,975 +1,195	+4%	+$73.2K	0.62%	41
2023 Q2	$2.16M	Sell	33,780 -825	-2%	-$55.3K	0.63%	42
2023 Q1	$2.4M	Buy	34,605 +6,724	+24%	+$474K	0.74%	34
2022 Q4	$2.01M	Buy	27,881 +4,864	+21%	+$367K	0.66%	38
2022 Q3	$1.64M	Buy	23,017 +16,620	+260%	+$1.21M	0.58%	44
2022 Q2	$492K	Buy	6,397 +145	+2%	+$11K	0.16%	85
2022 Q1	$457K	Buy	6,252 +197	+3%	+$13.2K	0.13%	92
2021 Q4	$378K	Buy	6,055 +56	+0.9%	+$3.29K	0.1%	113
2021 Q3	$355K	Sell	5,999 -59	-1%	-$3.88K	0.1%	113
2021 Q2	$411K	Sell	6,058 -323	-5%	-$21.1K	0.11%	105
2021 Q1	$402K	Buy	6,381 +55	+0.9%	+$3.42K	0.13%	97
2020 Q4	$392K	Buy	6,326 +997	+19%	+$61.3K	0.13%	92
2020 Q3	$321K	Buy	5,329 +159	+3%	+$9.57K	0.14%	94
2020 Q2	$304K	Buy	5,170 +5	+0.1%	+$299	0.14%	88
2020 Q1	$287K	Sell	5,165 -259	-5%	-$15.8K	0.16%	87
2019 Q4	$348K	Buy	+5,424	New	+$311K	0.16%	87